stockrow
Saturday 7 November 2026
Export CGNX’s income statement to Excel — free account
Cognex Corporation
CGNX Technology Scientific & Technical Instruments
Cognex Corporation’s revenue for fiscal 2025 (year ended December 2025) was $994.4 million, up 8.73% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +358.2%
- Free cash flow
- +20.6%
Quarter to September 2026, against a year earlier
47.78
0.28
+0.59%
Follow CGNX
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
35.95 | 60.18 | 30.45 | 47.49 | 79.23 | 48.91 | 38.34 | 61.12 | 57.84 | 52.14 |
Piotroski F-Score |
6 | 7 | 7 | 5 | 5 | 6 | 6 | 6 | 6 | 8 |
Altman Z-Score |
45.26 | 35.57 | 28.43 | 12.36 | 16.97 | 16.05 | 11.06 | 9.71 | 9.03 | 8.26 |
P/S ratio |
10.20 | 13.88 | 8.26 | 13.22 | 17.18 | 13.23 | 8.26 | 8.30 | 6.72 | 6.08 |
P/FCF ratio |
34.01 | 57.46 | 37.89 | 43.39 | 63.71 | 47.62 | 38.96 | 87.55 | 49.75 | 25.95 |
Altman Z″-Score (non-manufacturers) |
19.23 | 11.67 | 14.01 | 6.19 | 5.69 | 6.07 | 6.41 | 6.06 | 6.02 | 5.86 |
Beneish M-Score |
(2.39) | (1.88) | (2.57) | (2.35) | (2.53) | (2.53) | (2.61) | (2.48) | (2.39) | (2.78) |
P/Operating CF |
71.60 | 126.22 | 92.86 | 141.60 | 167.93 | 248.54 | 125.42 | 479.51 | 119.60 | 80.72 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 84 |
P/B ratio |
5.61 | 9.71 | 5.87 | 7.08 | 11.04 | 9.60 | 5.78 | 4.62 | 4.05 | 4.05 |
Price to Tangible BV |
6.29 | 10.97 | 6.59 | 8.94 | 13.89 | 11.66 | 7.02 | 6.96 | 5.90 | 5.90 |
EV/Sales |
9.40 | 13.36 | 7.60 | 12.65 | 16.72 | 12.92 | 7.86 | 7.90 | 6.45 | 5.74 |
EV/EBITDA |
29.37 | 37.06 | 25.24 | 55.02 | 68.36 | 39.37 | 29.21 | 42.87 | 39.86 | 29.64 |
EV/Operating CF |
27.35 | 45.61 | 27.43 | 36.25 | 55.93 | 42.66 | 32.50 | 58.60 | 39.59 | 23.26 |
EV/FCF |
31.36 | 55.28 | 34.84 | 41.53 | 62.01 | 46.50 | 37.09 | 83.37 | 47.76 | 24.50 |
Quick Ratio |
7.24 | 4.65 | 7.17 | 4.28 | 3.76 | 2.41 | 2.80 | 2.94 | 2.30 | 2.64 |
Current Ratio |
8.00 | 5.59 | 8.54 | 5.04 | 4.55 | 3.39 | 3.82 | 4.47 | 3.62 | 3.80 |
Net Debt/EBITDA |
(2.48) | (1.47) | (2.21) | (2.47) | (1.88) | (0.95) | (1.48) | (2.15) | (1.66) | (1.75) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.55 | 0.66 | 0.63 | 0.46 | 0.44 | 0.55 | 0.51 | 0.42 | 0.46 | 0.50 |
Operating CF/Net income |
1.27 | 1.27 | 1.02 | 1.24 | 1.38 | 1.12 | 1.13 | 1.00 | 1.40 | 2.15 |
Capex/Depreciation |
(0.83) | (1.67) | (1.71) | (0.90) | (0.48) | (0.61) | (0.80) | (0.98) | (0.46) | (0.07) |
| 16.07% | 17.17% | 19.66% | 16.37% | 13.46% | 20.79% | 15.03% | 7.69% | 7.03% | 7.61% | |
| 14.92% | 15.19% | 17.01% | 12.84% | 9.56% | 14.71% | 10.88% | 5.70% | 5.29% | 5.71% | |
ROIC |
17.77% | 23.41% | 23.05% | 9.44% | 11.98% | 17.80% | 14.82% | 6.97% | 5.66% | 8.80% |
Return on Tangible Assets |
27.93% | 29.68% | 28.10% | 35.38% | 32.12% | 52.93% | 35.35% | 17.89% | 19.57% | 19.08% |
Average Days of Receivables |
38.21 | 56.88 | 53.94 | 52.04 | 56.57 | 45.88 | 45.50 | 49.75 | 57.22 | 53.85 |
Research and Development Expense of Revenue |
14.78% | 12.95% | 14.44% | 16.46% | 16.15% | 13.05% | 14.03% | 16.64% | 15.29% | 13.98% |
Selling, General and Administrative Expense of Revenue |
31.37% | 28.81% | 32.58% | 37.74% | 32.99% | 29.83% | 31.02% | 40.49% | 40.56% | 36.59% |
Intangible Assets out of Total Assets |
0.10 | 0.10 | 0.10 | 0.15 | 0.14 | 0.13 | 0.13 | 0.25 | 0.24 | 0.23 |
Share Based Compensation of Revenue |
3.88% | 4.17% | 5.10% | 6.28% | 5.26% | 4.22% | 5.42% | 6.54% | 5.73% | 4.88% |
Graham Net Nets |
0.08 | 0.04 | 0.09 | 0.01 | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.03 |
Graham Number |
10.57 | 12.05 | 13.72 | 14.50 | 12.88 | 17.03 | 15.27 | 11.39 | 11.11 | 11.74 |
Earnings Yield |
2.78% | 1.66% | 3.28% | 2.11% | 1.26% | 2.04% | 2.61% | 1.64% | 1.73% | 1.92% |
Free Cash Flow Yield |
2.94% | 1.74% | 2.64% | 2.30% | 1.57% | 2.10% | 2.57% | 1.14% | 2.01% | 3.85% |
Revenue per Share |
3.10 | 4.42 | 4.68 | 4.24 | 4.67 | 5.88 | 5.80 | 4.86 | 5.33 | 5.92 |
Operating CF per Share |
1.07 | 1.29 | 1.30 | 1.48 | 1.40 | 1.78 | 1.40 | 0.66 | 0.87 | 1.46 |
Capex per Share |
(0.08) | (0.17) | (0.22) | (0.13) | (0.08) | (0.09) | (0.11) | (0.13) | (0.09) | (0.01) |
Free Cash Flow per Share |
0.99 | 1.13 | 1.08 | 1.35 | 1.32 | 1.69 | 1.29 | 0.52 | 0.78 | 1.45 |
Cash per Share |
2.47 | 2.33 | 3.11 | 2.41 | 2.15 | 1.83 | 2.31 | 1.93 | 1.44 | 2.01 |
Shareholders Equity per Share |
5.64 | 6.32 | 6.59 | 7.92 | 7.28 | 8.10 | 8.29 | 8.74 | 8.85 | 8.88 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
5.64 | 6.32 | 6.59 | 7.92 | 7.28 | 8.10 | 8.29 | 8.74 | 8.85 | 8.88 |
Free Cash Flow |
169.27 | 195.57 | 186.36 | 231.57 | 229.10 | 298.61 | 223.74 | 89.84 | 134.04 | 243.48 |
Working Capital |
460.57 | 517.36 | 688.97 | 486.75 | 469.39 | 451.21 | 529.99 | 527.11 | 443.99 | 513.70 |
Capital Expenditures |
(12.82) | (28.75) | (37.09) | (21.74) | (13.30) | (15.45) | (19.67) | (23.08) | (15.04) | (2.04) |
Net Current Asset Value |
450.34 | 437.91 | 625.92 | 77.01 | 63.19 | 66.23 | 197.95 | 165.94 | 138.02 | 172.59 |
EV/EBIT |
32.32 | 39.53 | 27.71 | 64.39 | 79.50 | 42.52 | 32.12 | 50.62 | 51.29 | 35.12 |
Capex to Sales |
0.02 | 0.04 | 0.05 | 0.03 | 0.02 | 0.01 | 0.02 | 0.03 | 0.02 | 0.00 |
Price to Operating Income |
35.05 | 41.09 | 30.14 | 67.28 | 81.68 | 43.55 | 33.75 | 53.16 | 53.43 | 37.19 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.29 | 0.22 | 0.24 | 0.27 | 0.35 | 0.32 | 0.31 | 0.22 | 0.34 | 0.35 |
Cash ROIC |
12.24% | 13.04% | 11.15% | 13.10% | 14.02% | 17.03% | 12.17% | 4.89% | 7.60% | 13.31% |
Accounts Receivable Turnover |
10.78 | 8.76 | 6.76 | 6.52 | 7.08 | 8.10 | 7.87 | 6.99 | 7.10 | 6.86 |
Accounts Payable Turnover |
14.82 | 11.25 | 10.38 | 11.13 | 12.09 | 9.19 | 7.99 | 9.73 | 9.70 | 7.46 |
Inventory Turnover |
4.08 | 3.95 | 2.73 | 2.64 | 3.41 | 3.19 | 2.41 | 1.66 | 1.81 | 2.23 |
Average Days of Payables |
27.37 | 45.73 | 28.75 | 34.37 | 28.77 | 57.99 | 34.81 | 33.14 | 48.10 | 55.70 |
Days of Inventory on Hand |
75.14 | 132.37 | 147.53 | 115.91 | 107.56 | 148.89 | 157.31 | 250.67 | 199.15 | 152.99 |
Average Receivables |
49.14 | 87.41 | 119.28 | 111.31 | 114.57 | 128.02 | 127.88 | 119.79 | 128.76 | 145.04 |
Average Payables |
8.85 | 16.65 | 19.85 | 17.05 | 17.07 | 30.16 | 35.58 | 24.28 | 29.75 | 44.12 |
Average Inventory |
32.16 | 47.45 | 75.60 | 71.77 | 60.55 | 86.97 | 117.79 | 142.38 | 159.91 | 147.71 |
Average Assets |
963.18 | 1,163.18 | 1,288.71 | 1,587.80 | 1,843.32 | 1,902.18 | 1,980.90 | 1,987.98 | 2,005.33 | 2,004.70 |
Average Common Equity |
894.13 | 1,029.14 | 1,115.47 | 1,245.49 | 1,308.96 | 1,346.15 | 1,434.24 | 1,471.57 | 1,511.13 | 1,504.70 |
Columns are period end dates · fundamentals updated 6 Nov 2026